6th Nitrosamines Impurities Workshop

As the USFDA, EMA and other regulatory agencies are determining and establishing acceptable intake limits for nitrosamines, the risk to patient safety still remains. As the studies evolves and guidelines refine, it is important to ensure you are updated with all the latest developments and upcoming deadlines that may impact your future.

For the 6th year in a row, Treffen Media has collaborated with the leading nitrosamine experts to bring you an updated agenda complete with latest impurities task force updates, compliance strategies and control and elimination roadmaps.